David Ungar

Head of US Oncology Clinical Development at ADC Therapeutics - New Providence, NJ, US

David Ungar's Colleagues at ADC Therapeutics
Einav Leberknight

Sr. Director, Clinical Operations

Contact Einav Leberknight

David Ellis

Vice President, Head of Regulatory Affairs

Contact David Ellis

Nick Finnie

Head of Intellectual Property

Contact Nick Finnie

View All David Ungar's Colleagues
David Ungar's Contact Details
HQ
908-731-5556
Location
New Providence, New Jersey
Company
ADC Therapeutics
David Ungar's Company Details
ADC Therapeutics logo, ADC Therapeutics contact details

ADC Therapeutics

New Providence, NJ, US • 250 - 499 Employees
BioTech/Drugs

ADC Therapeutics is a clinical-stage oncology biotechnology company leading the development and commercialization of next-generation antibody drug conjugates (ADCs) with highly potent and targeted pyrrolobenzodiazepine (PBD) dimer technology.  These proprietary PBD-based ADCs are expected to provide a novel way to treat hematological cancers and solid tumors, address significant unmet medical needs, and improve the lives of patients with cancer. Our mission is to confront cancer with the full potential of our science to bring unique, targeted therapies and hope to patients and their families.

N/A
Details about ADC Therapeutics
Frequently Asked Questions about David Ungar
David Ungar currently works for ADC Therapeutics.
David Ungar's role at ADC Therapeutics is Head of US Oncology Clinical Development.
David Ungar's email address is ***@adctherapeutics.com. To view David Ungar's full email address, please signup to ConnectPlex.
David Ungar works in the BioTech/Drugs industry.
David Ungar's colleagues at ADC Therapeutics are Einav Leberknight, David Ellis, Mike Cutcliff, Nick Finnie, Cristina Aller Garcia, Nicola Tsang, Veronica Gil and others.
David Ungar's phone number is 908-731-5556
See more information about David Ungar